Search Results - "Jérôme, Hanna"

New Hosts of The Lassa Virus by Olayemi, Ayodeji, Cadar, Daniel, Magassouba, N’Faly, Obadare, Adeoba, Kourouma, Fode, Oyeyiola, Akinlabi, Fasogbon, Samuel, Igbokwe, Joseph, Rieger, Toni, Bockholt, Sabrina, Jérôme, Hanna, Schmidt-Chanasit, Jonas, Garigliany, Mutien, Lorenzen, Stephan, Igbahenah, Felix, Fichet, Jean-Nicolas, Ortsega, Daniel, Omilabu, Sunday, Günther, Stephan, Fichet-Calvet, Elisabeth

“…Lassa virus (LASV) causes a deadly haemorrhagic fever in humans, killing several thousand people in West Africa annually. For 40 years, the Natal multimammate…”
Get full text

Role of the C terminus of Lassa virus L protein in viral mRNA synthesis by Lehmann, Maria, Pahlmann, Meike, Jérôme, Hanna, Busch, Carola, Lelke, Michaela, Günther, Stephan

“…The N terminus of arenavirus L protein contains an endonuclease presumably involved in "cap snatching." Here, we employed the Lassa virus replicon system to…”
Get full text

Production of biologically active recombinant human factor H in Physcomitrella by Büttner-Mainik, Annette, Parsons, Juliana, Jérôme, Hanna, Hartmann, Andrea, Lamer, Stephanie, Schaaf, Andreas, Schlosser, Andreas, Zipfel, Peter F, Reski, Ralf, Decker, Eva L

“…The human complement regulatory serum protein factor H (FH) is a promising future biopharmaceutical. Defects in the gene encoding FH are associated with human…”
Get more information

Rift Valley fever virus minigenome system for investigating the role of L protein residues in viral transcription and replication by Jérôme, Hanna, Rudolf, Martin, Lelke, Michaela, Pahlmann, Meike, Busch, Carola, Bockholt, Sabrina, Wurr, Stephanie, Günther, Stephan, Rosenthal, Maria, Kerber, Romy

“…Replicon systems are important tools for investigating viral RNA synthesis. We have developed an ambisense minigenome system for Rift Valley fever virus (RVFV)…”
Get full text

Widespread human exposure to ledanteviruses in Uganda: A population study by Shepherd, James G, Ashraf, Shirin, Salazar-Gonzalez, Jesus F, Salazar, Maria G, Downing, Robert G, Bukenya, Henry, Jerome, Hanna, Mpanga, Joseph T, Davis, Chris, Tong, Lily, Sreenu, Vattipally B, Atiku, Linda A, Logan, Nicola, Kajik, Ezekiel, Mukobi, Yafesi, Mungujakisa, Cyrus, Olowo, Michael V, Tibo, Emmanuel, Wunna, Fred, Jackson Ireland, Hollie, Blunsum, Andrew E, Owolabi, Iyanuoluwani, da Silva Filipe, Ana, Bwogi, Josephine, Willett, Brian J, Lutwama, Julius J, Streicker, Daniel G, Kaleebu, Pontiano, Thomson, Emma C

“…Le Dantec virus (LDV), assigned to the species Ledantevirus ledantec, genus Ledantevirus, family Rhabdoviridae has been associated with human disease but has…”
Get full text

Improved gastrointestinal profile with diroximel fumarate is associated with a positive impact on quality of life compared with dimethyl fumarate: results from the randomized, double-blind, phase III EVOLVE-MS-2 study by Wundes, Annette, Wray, Sibyl, Gold, Ralf, Singer, Barry A., Jasinska, Elzbieta, Ziemssen, Tjalf, de Seze, Jerome, Repovic, Pavle, Chen, Hailu, Hanna, Jerome, Messer, Jordan, Miller, Catherine, Naismith, Robert T.

“…Background: Diroximel fumarate (DRF) is a novel oral fumarate approved for relapsing forms of multiple sclerosis (MS). DRF demonstrated significantly improved…”
Get full text

Intentional Drug Poisoning Care in a Physician-manned Emergency Medical Service by Maignan, Maxime, Richard, Anais, Debaty, Guillaume, Pommier, Philippe, Viglino, Damien, Loizzo, François, Timsit, Jean-François, Hanna, Jérome, Carpentier, Françoise, Danel, Vincent

“…Abstract Objectives. Severely poisoned patients can benefit from intensive and specific treatments. Emergency medical services (EMS) may therefore play a…”
Get full text

NATALIZUMAB REDUCES MS RELAPSE RATES IN UK TOP PATIENTS by Nicholas, Richard, Hanna, Jerome

“…IntroductionThe Tysabri® Observational Program (TOP) is a 10-year, ongoing, global open-label study in clinical practice settings enrolling natalizumab-treated…”
Get full text

NATALIZUMAB FOR RELAPSING-REMITTING MS IN THE UK TOP COHORT by Nicholas, Richard, Hanna, Jerome

“…IntroductionThe TYSABRI registered Observational Program (TOP) is a global, open-label study of natalizumab for relapsing-remitting multiple sclerosis (RRMS)…”
Get full text

Diroximel Fumarate Demonstrates an Improved Gastrointestinal Tolerability Profile Compared with Dimethyl Fumarate in Patients with Relapsing–Remitting Multiple Sclerosis: Results from the Randomized, Double-Blind, Phase III EVOLVE-MS-2 Study by Naismith, Robert T., Wundes, Annette, Ziemssen, Tjalf, Jasinska, Elzbieta, Freedman, Mark S., Lembo, Anthony J., Selmaj, Krzysztof, Bidollari, Ilda, Chen, Hailu, Hanna, Jerome, Leigh-Pemberton, Richard, Lopez-Bresnahan, Maria, Lyons, Jennifer, Miller, Catherine, Rezendes, David, Wolinsky, Jerry S.

“…Background Diroximel fumarate (DRF) is a novel oral fumarate approved in the USA for relapsing forms of multiple sclerosis. DRF is converted to monomethyl…”
Get full text

Effect of dimethyl fumarate on lymphocytes in RRMS: Implications for clinical practice by Mehta, Devangi, Miller, Catherine, Arnold, Douglas L, Bame, Eris, Bar-Or, Amit, Gold, Ralf, Hanna, Jerome, Kappos, Ludwig, Liu, Shifang, Matta, André, Phillips, J Theodore, Robertson, Derrick, von Hehn, Christian A, Campbell, Jordana, Spach, Karen, Yang, Lili, Fox, Robert J

“…OBJECTIVETo assess functional changes in lymphocyte repertoire and subsequent clinical implications during delayed-release dimethyl fumarate (DMF) treatment in…”
Get full text

Metagenomic next-generation sequencing aids the diagnosis of viral infections in febrile returning travellers by Jerome, Hanna, Taylor, Callum, Sreenu, Vattipally B., Klymenko, Tanya, Filipe, Ana Da Silva, Jackson, Celia, Davis, Chris, Ashraf, Shirin, Wilson-Davies, Eleri, Jesudason, Natasha, Devine, Karen, Harder, Lisbeth, Aitken, Celia, Gunson, Rory, Thomson, Emma C.

“…•Next generation sequencing (NGS) has potential as an all-in-one diagnostic test for infection.•Viral, bacterial and parasite genomes can be detected…”
Get full text

Interim Safety and Efficacy Outcomes in Patients With Relapsing-Remitting Multiple Sclerosis who Received Diroximel Fumarate for Up to 2 Years (2228) by Wray, Sibyl, Singer, Barry A., Drulovic, Jelena, Chen, Hailu, Hanna, Jerome, Lyons, Jennifer, Bergh, Florian Then, Kapadia, Shivani, Negroski, Donald

“…Abstract only…”
Get full text

Effects of Diroximel Fumarate on Brain Volume Change and Disability Progression in Adults With Relapsing-Remitting Multiple Sclerosis From EVOLVE-MS-1 (1262) by Oh, Jiwon, Arnold, Douglas L., Singer, Barry A., Chen, Hailu, Hanna, Jerome, Miller, Catherine, Naismith, Robert T.

“…Abstract only…”
Get full text

Improving the Gastrointestinal Tolerability of Fumaric Acid Esters: Early Findings on Gastrointestinal Events with Diroximel Fumarate in Patients with Relapsing-Remitting Multiple Sclerosis from the Phase 3, Open-Label EVOLVE-MS-1 Study by Palte, Michael J., Wehr, Angela, Tawa, Mark, Perkin, Kristopher, Leigh-Pemberton, Richard, Hanna, Jerome, Miller, Catherine, Penner, Natasha

“…Introduction Diroximel fumarate (DRF) is a novel oral fumarate in development for patients with relapsing forms of multiple sclerosis (MS). Clinical findings…”
Get full text

Diroximel fumarate (DRF) in patients with relapsing–remitting multiple sclerosis: Interim safety and efficacy results from the phase 3 EVOLVE-MS-1 study by Naismith, Robert T, Wolinsky, Jerry S, Wundes, Annette, LaGanke, Christopher, Arnold, Douglas L, Obradovic, Dragana, Freedman, Mark S, Gudesblatt, Mark, Ziemssen, Tjalf, Kandinov, Boris, Bidollari, Ilda, Lopez-Bresnahan, Maria, Nangia, Narinder, Rezendes, David, Yang, Lili, Chen, Hailu, Liu, Shifang, Hanna, Jerome, Miller, Catherine, Leigh-Pemberton, Richard

“…Background: Diroximel fumarate (DRF) is a novel oral fumarate for patients with relapsing–remitting multiple sclerosis (RRMS). DRF and the approved drug…”
Get full text

Clinical Trial and Post-marketing Reports Indicate No Increased Risk of Herpes Zoster in Patients Treated With Delayed-release Dimethyl Fumarate (P5.362) by Hanna, Jerome, Prada, Claudia, Everage, Nicholas, Kalari, Sirisha, Chalkias, Spyros, Singhal, Priya, Smirnakis, Karen, Englishby, Veronica

“…Abstract only…”
Get full text

Efficacy of Delayed-Release Dimethyl Fumarate in Newly Diagnosed and Other Early Multiple Sclerosis Patients, and Patients Switching from Interferon or Glatiramer Acetate, in Routine Medical Practice: Interim Results from ESTEEM (P1.367) by Giles, Kathryn, Hanna, Jerome, Wu, Fan, Taylor, Catherine, Balashov, Konstantin, Macdonell, Richard, Windsheimer, Joerg, Everage, Nicholas

“…Abstract only…”
Get full text

053 Pregnancy outcomes with delayed-release dimethyl fumarate: interim results from an international registry by Everage, Nicholas J, Liu, Shifang, Yun, Jang, Prada, Claudia, Hanna, Jerome

“…IntroductionClinical trials and post marketing reports show no safety signals with delayed-release dimethyl fumarate (DMF) exposure during pregnancy; however,…”
Get full text

Pregnancy Outcomes From an International Registry of Patients Treated With Delayed-release Dimethyl Fumarate (P4.2-095) by Everage, Nicholas J., Jones, Cynthia C., Hellwig, Kerstin, Rog, David, Liu, Shifang, Mou, Jiani, Prada, Claudia, Hanna, Jerome

“…Abstract only…”
Get full text